In summary, our data demonstrate that mutant CK1e, which is present in ductal carcinoma, can act as an inhibitor of the Wnt/β-catenin and an activator of the noncanonical Wnt/Rac1/JNK and Wnt/Ca2+ pathways. This evidence concerns the gene MAPK8 and breast ductal adenocarcinoma.